PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
The public activities coordination tool (PACT) provides an overview of the substance-specific activities that authorities are working on under REACH and the CLP Regulation. These activities are being carried out in line with ECHA’s Integrated Regulatory Strategy.
PACT provides up-to-date information on the activities planned, ongoing or completed by ECHA and/or MSCAs for a given substance in the following areas:
- Data generation and assessment – dossier evaluation, substance evaluation, informal hazard assessment (PBT/vPvB/ED).
- Assessment of regulatory needs (ARN).
- Regulatory risk management – harmonised classification and labelling (CLH) , SVHC identification, recommendations for inclusion in the Authorisation List, restriction.
A summary of all the substance-specific activities can be found under ‘Details’ for each entry.
Further information
- Understanding PACT
- Integrated Regulatory Strategy
- Substances of potential concern
- Dossier Evaluation status
- Substance evaluation
- Endocrine disruptor assessment
- PBT assessment
- Assessment of regulatory needs list
- Registry of CLH intentions until outcome
- Registry of SVHC intentions until outcome
- Recommendations for inclusion in the Authorisation list
- Registry of restriction intentions until outcome
Filter the list
The List does not contain any Substances.
| Data generation and assessment | ARN | Regulatory risk management | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TCA | 211-479-2 | 650-51-1 | - | - | 2 | - | 1 | - | - | - | - | Details |
| Lysine hydrochloride | 211-519-9 | 657-27-2 | - | - | 1 | - | - | - | - | - | - | Details |
| Sodium toluene-4-sulphonate | 211-522-5 | 657-84-1 | - | - | 3 | - | - | - | - | - | - | Details |
| Docosan-1-ol | 211-546-6 | 661-19-8 | - | - | 2 | - | - | - | - | - | - | Details |
| (+)-N-(3-ethoxypropyl)-2,4-dihydroxy-3,3-dimethylbutyramide | 211-569-1 | 667-83-4 | - | - | - | - | 1 | - | - | - | - | Details |
| 2-phenylimidazole | 211-581-7 | 670-96-2 | - | - | 1 | - | 1 | - | - | - | - | Details |
| 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecan-1-ol | 211-648-0 | 678-39-7 | - | - | - | - | - | 2 | - | - | - | Details |
| Tetramethyl orthosilicate | 211-656-4 | 681-84-5 | - | - | - | - | 1 | - | - | - | - | Details |
| Tetrapropyl orthosilicate | 211-659-0 | 682-01-9 | - | - | - | - | 1 | - | - | - | - | Details |
| 2,2-bis(allyloxymethyl)butan-1-ol | 211-661-1 | 682-09-7 | - | - | 2 | - | - | - | - | - | - | Details |
| (carboxylatomethyl)dodecyldimethylammonium | 211-669-5 | 683-10-3 | - | - | - | - | 1 | - | - | - | - | Details |
| Dibutyltin dichloride | 211-670-0 | 683-18-1 | - | - | - | - | - | - | 1 | - | - | Details |
| tert-pentyl 2-ethylperoxyhexanoate | 211-687-3 | 686-31-7 | - | - | 1 | - | - | - | - | - | - | Details |
| Ethyl (S)-2-hydroxypropionate | 211-694-1 | 687-47-8 | - | - | 2 | - | - | - | - | - | - | Details |
| 2-ethylhexyl methacrylate | 211-708-6 | 688-84-6 | - | - | 3 | - | 1 | - | - | - | - | Details |
| Oxydiethylene dinitrate | 211-745-8 | 693-21-0 | 1 | - | - | - | - | - | - | - | - | Details |
| Dodecanedioic acid | 211-746-3 | 693-23-2 | - | - | 2 | - | - | - | - | - | - | Details |
| (carboxylatomethyl)hexadecyldimethylammonium | 211-748-4 | 693-33-4 | - | - | - | - | 1 | - | - | - | - | Details |
| Dioctadecyl 3,3'-thiodipropionate | 211-750-5 | 693-36-7 | - | - | 3 | - | - | - | - | - | - | Details |
| 2-methylimidazole | 211-765-7 | 693-98-1 | - | - | - | - | 2 | 1 | 1 | - | - | Details |
| Cyclohex-1,2-ylenediamine | 211-776-7 | 694-83-7 | - | - | 4 | - | 1 | - | - | - | - | Details |
| Hexan-4-olide | 211-778-8 | 695-06-7 | - | - | 1 | - | - | - | - | - | - | Details |
| Isopropylcyclohexane | 211-792-4 | 696-29-7 | - | - | 2 | - | 1 | - | - | - | - | Details |
| 2,3,5-trimethylphenol | 211-806-9 | 697-82-5 | - | - | 1 | - | - | - | - | - | - | Details |
| 2',6'-dihydroxyacetophenone | 211-833-6 | 699-83-2 | - | - | - | - | 1 | - | - | - | - | Details |